Frontiers in Endocrinology

Frontiers in Endocrinology

FRONT ENDOCRINOL
影响因子:4.6
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Frontiers Media S.A.
发刊时间:0
发刊频率:
收录数据库:SCIE/Scopus收录/DOAJ开放期刊
ISSN:1664-2392

期刊介绍

Frontiers in Endocrinology is a field journal of the "Frontiers in" journal series. In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology.Frontiers in Endocrinology publishes articles on the most outstanding discoveries across a wide research spectrum of Endocrinology. The mission of Frontiers in Endocrinology is to bring all relevant Endocrinology areas together on a single platform.
Frontiers in Endocrinology是“Frontiers in”期刊系列的领域期刊。在当今世界,内分泌学变得越来越重要,因为它是社会面临的许多挑战的基础——从肥胖和糖尿病到生育、人口控制和老龄化。内分泌学涵盖从基本分子和细胞通讯到临床护理和一些最重要的公共卫生问题的广泛领域。因此,该杂志欢迎内分泌学任何领域的杰出贡献。内分泌学前沿发表关于内分泌学广泛研究领域最杰出发现的文章。 Frontiers in Endocrinology的使命是将所有相关的内分泌学领域整合到一个平台上。
年发文量 2283
国人发稿量 1295.37
国人发文占比 0.57%
自引率 -
平均录取率-
平均审稿周期 14 Weeks
版面费 US$2950
偏重研究方向 Medicine-Endocrinology, Diabetes and Metabolism
期刊官网 https://www.frontiersin.org/journals/endocrinology
投稿链接 https://www.frontiersin.org/people/login?returnUrl=https%3a%2f%2fwww.frontiersin.org%2fsubmission%2fSubmissionHome.aspx%3fdomainId%3d2%26fieldId%3d23%26specialtyId%3d0%26entityType%3d1%26entityId%3d106

期刊高被引文献

Genetic Associations With Diabetic Retinopathy and Coronary Artery Disease in Emirati Patients With Type-2 Diabetes Mellitus
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00283
Obesity May Accelerate the Aging Process
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00266
Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2018.00778
Gut Bacteriophage: Current Understanding and Challenges
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00784
Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00387
Environmental Factors Associated With Type 1 Diabetes
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00592
Inverse Association Between Serum Vitamin B12 Concentration and Obesity Among Adults in the United States
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00414
Vitamin D Binding Protein and the Biological Activity of Vitamin D
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00718
Gut Dysfunction and Non-alcoholic Fatty Liver Disease
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00611
Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00641
A1C Underperforms as a Diagnostic Test in Africans Even in the Absence of Nutritional Deficiencies, Anemia and Hemoglobinopathies: Insight From the Africans in America Study
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00533
Melanocortin Regulation of Inflammation
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00683
Nutrient Sensing by Hypothalamic Tanycytes
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00244
Genetics of Growth Disorders—Which Patients Require Genetic Testing?
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00602
Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00413
Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00640
Nivolumab Induced Thyroid Dysfunction: Unusual Clinical Presentation and Challenging Diagnosis
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2018.00813
Integrative Analysis Toward Different Glucose Tolerance-Related Gut Microbiota and Diet
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00295
Standardised Nomenclature, Abbreviations, and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow Adiposity Society
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00923
Central Mechanism Controlling Pubertal Onset in Mammals: A Triggering Role of Kisspeptin
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00312
Sex Differences in the Prevalence, Awareness, Treatment, and Control of Diabetes Mellitus Among Adults Aged 45 Years and Older in Rural Areas of Northern China: A Cross-Sectional, Population-Based Study
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00147
Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00401
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00552
Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2018.00757
Cyclophosphamide Regulates N6-Methyladenosine and m6A RNA Enzyme Levels in Human Granulosa Cells and in Ovaries of a Premature Ovarian Aging Mouse Model
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00415
Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00717
Protective Effect of Resveratrol on Benzo(a)Pyrene Induced Dysfunctions of Steroidogenesis and Steroidogenic Acute Regulatory Gene Expression in Leydig Cells
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00272
Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00642
Role of MicroRNAs in the Regulation of Subcutaneous White Adipose Tissue in Individuals With Obesity and Without Type 2 Diabetes
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00840
Circulating miRNA Expression Profiling in Primary Aldosteronism
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00739
The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00189
Chordin-Like 1 Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells Through Enhancing BMP4-SMAD Pathway
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00360
Adipsic Diabetes Insipidus—The Challenging Combination of Polyuria and Adipsia: A Case Report and Review of Literature
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00630
Disposition Index in Active Acromegaly
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00637
Corrigendum: Molecular Network Basis of Invasive Pituitary Adenoma: A Review
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00657
Integrated Analysis of mRNA and miRNA Expression Profiles in the Ovary of Oryctolagus cuniculus in Response to Gonadotrophic Stimulation
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00744
miR-181b-5p May Regulate Muscle Growth in Tilapia by Targeting Myostatin b
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00812
Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00004
The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00394
Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00040
Exposure to the UV Filter Octyl Methoxy Cinnamate in the Postnatal Period Induces Thyroid Dysregulation and Perturbs the Immune System of Mice
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00943
Abnormal Thyroid Hormone Status Differentially Affects Bone Mass Accrual and Bone Strength in C3H/HeJ Mice: A Mouse Model of Type I Deiodinase Deficiency
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00300
Treatment of Hypothyroid Patients With L-Thyroxine (L-T4) Plus Triiodothyronine Sulfate (T3S). A Phase II, Open-Label, Single Center, Parallel Groups Study on Therapeutic Efficacy and Tolerability
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00826
Associations Between the Apolipoprotein E ε4 Allele and Reduced Serum Levels of High Density Lipoprotein a Cognitively Normal Aging Han Chinese Population
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00827
A Comparative Peptidomic Characterization of Cultured Skeletal Muscle Tissues Derived From db/db Mice
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00741
Testicular Cancer—Surgical Treatment
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00308
Sleep Duration and Diabetic Kidney Disease
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2018.00808
A Rare Aldosterone-Producing Adenoma Detected by 68Ga-pentixafor PET-CT: A Case Report and Literature Review
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00810
Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00636
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs)
来源期刊:Frontiers in EndocrinologyDOI:10.3389/fendo.2019.00512

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
81.34%99.31%-1.76%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ENDOCRINOLOGY & METABOLISM
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
3区
2023年12月升级版
医学2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区
2022年12月旧的升级版
医学2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区